Auris Medical AG
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Public, Subsidiary
- Established
- 2003-04-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.aurismedical.com
AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
Phase 2
Completed
- Conditions
- Vestibular Vertigo
- Interventions
- Other: Intranasal PlaceboDrug: Intranasal DrugDrug: Oral Tablet
- First Posted Date
- 2019-04-09
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Auris Medical AG
- Target Recruit Count
- 124
- Registration Number
- NCT03908567
- Locations
- π«π·
CHP Clairval, Marseille, France
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
Phase 3
Completed
- Conditions
- Hearing Loss
- Interventions
- Other: PlaceboDrug: AM-111 0.4 mg/mlDrug: AM-111 0.8 mg/ml
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Auris Medical AG
- Target Recruit Count
- 256
- Registration Number
- NCT02561091
- Locations
- π§π¬
Please check link to study webpage below for more study sites, Sofia, Bulgaria
AM-101 in the Treatment of Acute Tinnitus 3
Phase 3
Completed
- Conditions
- Tinnitus
- Interventions
- Drug: AM-101Drug: Placebo
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Auris Medical AG
- Target Recruit Count
- 893
- Registration Number
- NCT02040194
- Locations
- π©πͺ
Please check the study webpage below for a study site list, Munich, Germany
AM-101 in the Treatment of Post-Acute Tinnitus 2
Phase 3
Completed
- Conditions
- Tinnitus
- Interventions
- Drug: AM-101
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Auris Medical AG
- Target Recruit Count
- 487
- Registration Number
- NCT02040207
- Locations
- π©πͺ
Investigational site, Munich, Germany
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
Phase 2
Completed
- Conditions
- Tinnitus
- Interventions
- Drug: AM-101
- First Posted Date
- 2009-03-12
- Last Posted Date
- 2013-02-13
- Lead Sponsor
- Auris Medical AG
- Target Recruit Count
- 248
- Registration Number
- NCT00860808
- Locations
- π©πͺ
Bundeswehrkrankenhaus Ulm, Ulm, Germany
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Auris Medical AG
- Target Recruit Count
- 210
- Registration Number
- NCT00802425
- Locations
- π©πͺ
LMU Munich Klinikum Grosshadern, Munich, Germany
Β© Copyright 2025. All Rights Reserved by MedPath